| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |